Regulation of superoxide dismutase genes: Implications in disease

Free Radical Biology and Medicine

Volumn 47, Issue 4, 2009, Pages 344-356

  Miao, Lu ^a   St Clair, Daret K ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Free radicals; Gene regulation; Oxidative stress related disease; Superoxide dismutase

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SP1;

ADVANCED CANCER; AMYOTROPHIC LATERAL SCLEROSIS; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVITY; EPIGENETICS; GENE CONSTRUCT; GENE CONTROL; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; GENE STRUCTURE; GENE TARGETING; GENETIC ASSOCIATION; GENETIC ORGANIZATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR INTERACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; RNA STABILITY; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TRANSCRIPTION REGULATION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; REACTIVE OXYGEN SPECIES; REGULATORY SEQUENCES, NUCLEIC ACID; STRUCTURE-ACTIVITY RELATIONSHIP; SUPEROXIDE DISMUTASE;

EID: 67649840689     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.05.018     Document Type: Review

References (190)

1. Evans M.D., Dizdaroglu M., and Cooke M.S. Oxidative DNA damage and disease: induction, repair and significance. Mutat. Res. 567 (2004) 1-61
2. Chen A.F., Davies C.M., De Lin M., and Fermor B. Oxidative DNA damage in osteoarthritic porcine articular cartilage. J. Cell. Physiol. 217 (2008) 828-833
3. Xie L., Zhu X., Hu Y., Li T., Gao Y., Shi Y., and Tang S. Mitochondrial DNA oxidative damage triggering mitochondrial dysfunction and apoptosis in high glucose-induced HRECs. Investig. Ophthalmol. Vis. Sci. 49 (2008) 4203-4209
4. Sun Y., and Oberley L.W. Redox regulation of transcriptional activators. Free Radic. Biol. Med. 21 (1996) 335-348
5. Cai J., Yang J., and Jones D.P. Mitochondrial control of apoptosis: the role of cytochrome c. Biochim. Biophys. Acta 1366 (1998) 139-149
6. Giannattasio S., Atlante A., Antonacci L., Guaragnella N., Lattanzio P., Passarella S., and Marra E. Cytochrome c is released from coupled mitochondria of yeast en route to acetic acid-induced programmed cell death and can work as an electron donor and a ROS scavenger. FEBS Lett. 582 (2008) 1519-1525
7. 2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am. J. Physiol, Heart Circ. Physiol. 294 (2008) H570-578
8. Scherz-Shouval R., and Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol. 17 (2007) 422-427
9. McCord J.M., and Fridovich I. Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244 (1969) 6049-6055
10. Parge H.E., Hallewell R.A., and Tainer J.A. Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase. Proc. Natl. Acad. Sci. USA 89 (1992) 6109-6113
11. Fridovich I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 64 (1995) 97-112
12. Harvey L.J., and McArdle H.J. Biomarkers of copper status: a brief update. Br. J. Nutr. 99 Suppl. 3 (2008) S10-13
13. Carroll M.C., Girouard J.B., Ulloa J.L., Subramaniam J.R., Wong P.C., Valentine J.S., and Culotta V.C. Mechanisms for activating Cu- and Zn-containing superoxide dismutase in the absence of the CCS Cu chaperone. Proc. Natl. Acad. Sci. USA 101 (2004) 5964-5969
14. Kayatekin C., Zitzewitz J.A., and Matthews C.R. Zinc binding modulates the entire folding free energy surface of human Cu,Zn superoxide dismutase. J. Mol. Biol. 384 (2008) 540-555
15. Luk E.E., and Culotta V.C. Manganese superoxide dismutase in Saccharomyces cerevisiae acquires its metal co-factor through a pathway involving the Nramp metal transporter, Smf2p. J. Biol. Chem. 276 (2001) 47556-47562
16. Luk E., Carroll M., Baker M., and Culotta V.C. Manganese activation of superoxide dismutase 2 in Saccharomyces cerevisiae requires MTM1, a member of the mitochondrial carrier family. Proc. Natl. Acad. Sci. USA 100 (2003) 10353-10357
17. Luk E., Yang M., Jensen L.T., Bourbonnais Y., and Culotta V.C. Manganese activation of superoxide dismutase 2 in the mitochondria of Saccharomyces cerevisiae. J. Biol. Chem. 280 (2005) 22715-22720
18. Itoh S., Ozumi K., Kim H.W., Nakagawa O., McKinney R.D., Folz R.J., Zelko I.N., Ushio-Fukai M., and Fukai T. Novel mechanism for regulation of extracellular SOD transcription and activity by copper: role of antioxidant-1. Free Radic. Biol. Med. 46 (2009) 95-104
19. Qin Z., Gongora M.C., Ozumi K., Itoh S., Akram K., Ushio-Fukai M., Harrison D.G., and Fukai T. Role of Menkes ATPase in angiotensin II-induced hypertension: a key modulator for extracellular superoxide dismutase function. Hypertension 52 (2008) 811-812
20. Zelko I.N., Mariani T.J., and Folz R.J. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic. Biol. Med. 33 (2002) 337-349
21. 2 in studies of signal transduction. Free Radic. Biol. Med. 42 (2007) 926-932
22. Liu B., Chen Y., and St Clair D.K. ROS and p53: a versatile partnership. Free Radic. Biol. Med. 44 (2008) 1529-1535
23. Kalmar B., Novoselov S., Gray A., Cheetham M.E., Margulis B., and Greensmith L. Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1 mouse model of ALS. J. Neurochem. 107 (2008) 339-350
24. Joseph A., Li Y., Koo H.C., Davis J.M., Pollack S., and Kazzaz J.A. Superoxide dismutase attenuates hyperoxia-induced interleukin-8 induction via AP-1. Free Radic. Biol. Med. 45 (2008) 1143-1149
25. Pawlak K., Domaniewski T., Mysliwiec M., and Pawlak D. The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease. Atherosclerosis 204 (2008) 309-314
26. Kaewpila S., Venkataraman S., Buettner G.R., and Oberley L.W. Manganese superoxide dismutase modulates hypoxia-inducible factor-1 alpha induction via superoxide. Cancer Res. 68 (2008) 2781-2788
27. Oberley L.W. Anticancer therapy by overexpression of superoxide dismutase. Antioxid. Redox Signal. 3 (2001) 461-472
28. Hsu J.L., Visner G.A., Burr I.A., and Nick H.S. Rat copper/zinc superoxide dismutase gene: isolation, characterization, and species comparison. Biochem. Biophys. Res. Commun. 186 (1992) 936-943
29. Schmutz S.M., Cornwell D., Moker J.S., and Troyer D.L. Physical mapping of SOD1 to bovine chromosome 1. Cytogenet. Cell Genet. 72 (1996) 37-39
30. Levanon D., Lieman-Hurwitz J., Dafni N., Wigderson M., Sherman L., Bernstein Y., Laver-Rudich Z., Danciger E., Stein O., and Groner Y. Architecture and anatomy of the chromosomal locus in human chromosome 21 encoding the Cu/Zn superoxide dismutase. EMBO J. 4 (1985) 77-84
31. Jones P.L., Kucera G., Gordon H., and Boss J.M. Cloning and characterization of the murine manganous superoxide dismutase-encoding gene. Gene 153 (1995) 155-161
32. DiSilvestre D., Kleeberger S.R., Johns J., and Levitt R.C. Structure and DNA sequence of the mouse MnSOD gene. Mamm. Genome 6 (1995) 281-284
33. Ho Y.S., Howard A.J., and Crapo J.D. Molecular structure of a functional rat gene for manganese-containing superoxide dismutase. Am. J. Respir. Cell Mol. Biol. 4 (1991) 278-286
34. Meyrick B., and Magnuson M.A. Identification and functional characterization of the bovine manganous superoxide dismutase promoter. Am. J. Respir. Cell Mol. Biol. 10 (1994) 113-121
35. Marlhens F., Nicole A., and Sinet P.M. Lowered level of translatable messenger RNAs for manganese superoxide dismutase in human fibroblasts transformed by SV 40. Biochem. Biophys. Res. Commun. 129 (1985) 300-305
36. Wan X.S., Devalaraja M.N., and St Clair D.K. Molecular structure and organization of the human manganese superoxide dismutase gene. DNA Cell Biol. 13 (1994) 1127-1136
37. Hjalmarsson K., Marklund S.L., Engstrom A., and Edlund T. Isolation and sequence of complementary DNA encoding human extracellular superoxide dismutase. Proc. Natl. Acad. Sci. USA 84 (1987) 6340-6344
38. Folz R.J., and Crapo J.D. Extracellular superoxide dismutase (SOD3): tissue-specific expression, genomic characterization, and computer-assisted sequence analysis of the human EC SOD gene. Genomics 22 (1994) 162-171
39. Perry A.C., Jones R., and Hall L. Isolation and characterization of a rat cDNA clone encoding a secreted superoxide dismutase reveals the epididymis to be a major site of its expression. Biochem. J. 293 Pt 1 (1993) 21-25
40. Folz R.J., Guan J., Seldin M.F., Oury T.D., Enghild J.J., and Crapo J.D. Mouse extracellular superoxide dismutase: primary structure, tissue-specific gene expression, chromosomal localization, and lung in situ hybridization. Am. J. Respir. Cell Mol. Biol. 17 (1997) 393-403
41. Hoffmann A., Natoli G., and Ghosh G. Transcriptional regulation via the NF-kappaB signaling module. Oncogene 25 (2006) 6706-6716
42. Fattman C.L., Schaefer L.M., and Oury T.D. Extracellular superoxide dismutase in biology and medicine. Free Radic. Biol. Med. 35 (2003) 236-256
43. Xu Y., Kiningham K.K., Devalaraja M.N., Yeh C.C., Majima H., Kasarskis E.J., and St Clair D.K. An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta. DNA Cell Biol. 18 (1999) 709-722
44. Minc E., de Coppet P., Masson P., Thiery L., Dutertre S., Amor-Gueret M., and Jaulin C. The human copper-zinc superoxide dismutase gene (SOD1) proximal promoter is regulated by Sp1, Egr-1, and WT1 via non-canonical binding sites. J. Biol. Chem. 274 (1999) 503-509
45. Rojo A.I., Salinas M., Martin D., Perona R., and Cuadrado A. Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaB. J. Neurosci. 24 (2004) 7324-7334
46. Mumbengegwi D.R., Li Q., Li C., Bear C.E., and Engelhardt J.F. Evidence for a superoxide permeability pathway in endosomal membranes. Mol. Cell. Biol. 28 (2008) 3700-3712
47. Dimayuga F.O., Wang C., Clark J.M., Dimayuga E.R., Dimayuga V.M., and Bruce-Keller A.J. SOD1 overexpression alters ROS production and reduces neurotoxic inflammatory signaling in microglial cells. J. Neuroimmunol. 182 (2007) 89-99
48. Beni S.M., Tsenter J., Alexandrovich A.G., Galron-Krool N., Barzilai A., Kohen R., Grigoriadis N., Simeonidou C., and Shohami E. CuZn-SOD deficiency, rather than overexpression, is associated with enhanced recovery and attenuated activation of NF-kappaB after brain trauma in mice. J. Cereb. Blood Flow Metab. 26 (2006) 478-490
49. Eastgate J., Moreb J., Nick H.S., Suzuki K., Taniguchi N., and Zucali J.R. A role for manganese superoxide dismutase in radioprotection of hematopoietic stem cells by interleukin-1. Blood 81 (1993) 639-646
50. Akashi M., Hachiya M., Paquette R.L., Osawa Y., Shimizu S., and Suzuki G. Irradiation increases manganese superoxide dismutase mRNA levels in human fibroblasts: possible mechanisms for its accumulation. J. Biol. Chem. 270 (1995) 15864-15869
51. Fujii J., and Taniguchi N. Phorbol ester induces manganese-superoxide dismutase in tumor necrosis factor-resistant cells. J. Biol. Chem. 266 (1991) 23142-23146
52. Harris C.A., Derbin K.S., Hunte-McDonough B., Krauss M.R., Chen K.T., Smith D.M., and Epstein L.B. Manganese superoxide dismutase is induced by IFN-gamma in multiple cell types: synergistic induction by IFN-gamma and tumor necrosis factor or IL-1. J. Immunol. 147 (1991) 149-154
53. Wong G.H., Elwell J.H., Oberley L.W., and Goeddel D.V. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58 (1988) 923-931
54. Wong G.H., and Goeddel D.V. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 242 (1988) 941-944
55. Visner G.A., Dougall W.C., Wilson J.M., Burr I.A., and Nick H.S. Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor: role in the acute inflammatory response. J. Biol. Chem. 265 (1990) 2856-2864
56. Dougall W.C., and Nick H.S. Manganese superoxide dismutase: a hepatic acute phase protein regulated by interleukin-6 and glucocorticoids. Endocrinology 129 (1991) 2376-2384
57. St Clair D.K., Porntadavity S., Xu Y., and Kiningham K. Transcription regulation of human manganese superoxide dismutase gene. Methods Enzymol. 349 (2002) 306-312
58. Kiningham K.K., Xu Y., Daosukho C., Popova B., and St Clair D.K. Nuclear factor kappaB-dependent mechanisms coordinate the synergistic effect of PMA and cytokines on the induction of superoxide dismutase 2. Biochem. J. 353 (2001) 147-156
59. Guo Z., Boekhoudt G.H., and Boss J.M. Role of the intronic enhancer in tumor necrosis factor-mediated induction of manganous superoxide dismutase. J. Biol. Chem. 278 (2003) 23570-23578
60. Rogers R.J., Chesrown S.E., Kuo S., Monnier J.M., and Nick H.S. Cytokine-inducible enhancer with promoter activity in both the rat and human manganese-superoxide dismutase genes. Biochem. J. 347 Pt 1 (2000) 233-242
61. Dhar S.K., Xu Y., Noel T., and St Clair D.K. Chronic exposure to 12-O-tetradecanoylphorbol-13-acetate represses sod2 induction in vivo: the negative role of p50. Carcinogenesis 28 (2007) 2605-2613
62. Marklund S.L. Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts. J. Biol. Chem. 267 (1992) 6696-6701
63. Brady T.C., Chang L.Y., Day B.J., and Crapo J.D. Extracellular superoxide dismutase is upregulated with inducible nitric oxide synthase after NF-kappa B activation. Am. J. Physiol. 273 (1997) L1002-1006
64. Dynan W.S., and Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 35 (1983) 79-87
65. Briggs M.R., Kadonaga J.T., Bell S.P., and Tjian R. Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science 234 (1986) 47-52
66. Dynan W.S., and Tjian R. Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase II. Cell 32 (1983) 669-680
67. Xu Y., Porntadavity S., and St Clair D.K. Transcriptional regulation of the human manganese superoxide dismutase gene: the role of specificity protein 1 (Sp1) and activating protein-2 (AP-2). Biochem. J. 362 (2002) 401-412
68. Yeh C.C., Wan X.S., and St Clair D.K. Transcriptional regulation of the 5′ proximal promoter of the human manganese superoxide dismutase gene. DNA Cell Biol. 17 (1998) 921-930
69. Seo S.J., Kim H.T., Cho G., Rho H.M., and Jung G. Sp1 and C/EBP-related factor regulate the transcription of human Cu/Zn SOD gene. Gene 178 (1996) 177-185
70. Afonso V., Santos G., Collin P., Khatib A.M., Mitrovic D.R., Lomri N., Leitman D.C., and Lomri A. Tumor necrosis factor-alpha down-regulates human Cu/Zn superoxide dismutase 1 promoter via JNK/AP-1 signaling pathway. Free Radic. Biol. Med. 41 (2006) 709-721
71. Baldelli S., Aquilano K., Rotilio G., and Ciriolo M.R. Glutathione and copper, zinc superoxide dismutase are modulated by overexpression of neuronal nitric oxide synthase. Int. J. Biochem. Cell Biol. 40 (2008) 2660-2670
72. Tanaka T., Kurabayashi M., Aihara Y., Ohyama Y., and Nagai R. Inducible expression of manganese superoxide dismutase by phorbol 12-myristate 13-acetate is mediated by Sp1 in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 392-401
73. Kuo S., Chokas A.L., Rogers R.J., and Nick H.S. PIN*POINT analysis on the endogenous MnSOD promoter: specific demonstration of Sp1 binding in vivo. Am. J. Physiol., Cell Physiol. 284 (2003) C528-C534
74. Mastrangelo I.A., Courey A.J., Wall J.S., Jackson S.P., and Hough P.V. DNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement. Proc. Natl. Acad. Sci. USA 88 (1991) 5670-5674
75. Xu Y., Fang F., Dhar S.K., St Clair W.H., Kasarskis E.J., and St Clair D.K. The role of a single-stranded nucleotide loop in transcriptional regulation of the human sod2 gene. J. Biol. Chem. 282 (2007) 15981-15994
76. Dhar S.K., Xu Y., Chen Y., and St Clair D.K. Specificity protein 1-dependent p53-mediated suppression of human manganese superoxide dismutase gene expression. J. Biol. Chem. 281 (2006) 21698-21709
77. Zelko I.N., and Folz R.J. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase. Free Radic. Biol. Med. 37 (2004) 1256-1271
78. Zelko N., Mueller M.R., and Folz R.J. Transcription factors sp1 and sp3 regulate expression of human extracellular superoxide dismutase in lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 39 (2008) 243-251
79. Angel P., and Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072 (1991) 129-157
80. Huang C.Y., Fujimura M., Chang Y.Y., and Chan P.H. Overexpression of copper-zinc superoxide dismutase attenuates acute activation of activator protein-1 after transient focal cerebral ischemia in mice. Stroke 32 (2001) 741-747
81. Zhou W., Zhang Y., Hosch M.S., Lang A., Zwacka R.M., and Engelhardt J.F. Subcellular site of superoxide dismutase expression differentially controls AP-1 activity and injury in mouse liver following ischemia/reperfusion. Hepatology 33 (2001) 902-914
82. Zhao Y., Oberley T.D., Chaiswing L., Lin S.M., Epstein C.J., Huang T.T., and St Clair D. Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model. Oncogene 21 (2002) 3836-3846
83. Qadri I., Iwahashi M., Capasso J.M., Hopken M.W., Flores S., Schaack J., and Simon F.R. Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1. Biochem. J. 378 (2004) 919-928
84. Eckert D., Buhl S., Weber S., Jager R., and Schorle H. The AP-2 family of transcription factors. Genome Biol. 6 (2005) 246
85. Xu Y., Fang F., Dhar S.K., Bosch A., St Clair W.H., Kasarskis E.J., and St Clair D.K. Mutations in the SOD2 promoter reveal a molecular basis for an activating protein 2-dependent dysregulation of manganese superoxide dismutase expression in cancer cells. Mol. Cancer Res. 6 (2008) 1881-1893
86. Kim Y.H., Park K.H., and Rho H.M. Transcriptional activation of the Cu,Zn-superoxide dismutase gene through the AP2 site by ginsenoside Rb2 extracted from a medicinal plant, Panax ginseng. J. Biol. Chem. 271 (1996) 24539-24543
87. Zhu C., Huang Y., Weydert C.J., Oberley L.W., and Domann F.E. Constitutive activation of transcription factor AP-2 is associated with decreased MnSOD expression in transformed human lung fibroblasts. Antioxid. Redox Signal. 3 (2001) 387-395
88. Zhu C.H., Huang Y., Oberley L.W., and Domann F.E. A family of AP-2 proteins down-regulate manganese superoxide dismutase expression. J. Biol. Chem. 276 (2001) 14407-14413
89. Huang Y., Peng J., Oberley L.W., and Domann F.E. Transcriptional inhibition of manganese superoxide dismutase (SOD2) gene expression by DNA methylation of the 5′ CpG island. Free Radic. Biol. Med. 23 (1997) 314-320
90. Ramji D.P., and Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365 (2002) 561-575
91. Seo S.J., Kang S.S., Cho G., Rho H.M., and Jung G. C/EBP alpha and C/EBPbeta play similar roles in the transcription of the human Cu/Zn SOD gene. Gene 203 (1997) 11-15
92. Kim Y.H., Yoo H.Y., Chang M.S., Jung G., and Rho H.M. C/EBP alpha is a major activator for the transcription of rat Cu/Zn superoxide dismutase gene in liver cell. FEBS Lett. 401 (1997) 267-270
93. Qiu X., Aiken K.J., Chokas A.L., Beachy D.E., and Nick H.S. Distinct functions of CCAAT enhancer-binding protein isoforms in the regulation of manganese superoxide dismutase during interleukin-1beta stimulation. J. Biol. Chem. 283 (2008) 25774-25785
94. Adachi T., Inoue M., Hara H., and Suzuki S. Effects of PPARgamma ligands and C/EBPbeta enhancer on expression of extracellular-superoxide dismutase. Redox Rep. 9 (2004) 207-212
95. Yoo H.Y., Chang M.S., and Rho H.M. Induction of the rat Cu/Zn superoxide dismutase gene through the peroxisome proliferator-responsive element by arachidonic acid. Gene 234 (1999) 87-91
96. Chang M.S., Yoo H.Y., and Rho H.M. Positive and negative regulatory elements in the upstream region of the rat Cu/Zn-superoxide dismutase gene. Biochem. J. 339 Pt 2 (1999) 335-341
97. Cho G., Kang S., Seo S.J., Kim Y., and Jung G. The transcriptional repression of the human Cu/Zn superoxide dismutase (sod1) gene by the anticancer drug, mitomycin C (MMC). Biochem. Mol. Biol. Int. 42 (1997) 949-956
98. Park E.Y., and Rho H.M. The transcriptional activation of the human copper/zinc superoxide dismutase gene by 2,3,7,8-tetrachlorodibenzo-p-dioxin through two different regulator sites, the antioxidant responsive element and xenobiotic responsive element. Mol. Cell. Biochem. 240 (2002) 47-55
99. Kops G.J., Dansen T.B., Polderman P.E., Saarloos I., Wirtz K.W., Coffer P.J., Huang T.T., Bos J.L., Medema R.H., and Burgering B.M. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419 (2002) 316-321
100. Li M., Chiu J.F., Mossman B.T., and Fukagawa N.K. Down-regulation of manganese-superoxide dismutase through phosphorylation of FOXO3a by Akt in explanted vascular smooth muscle cells from old rats. J. Biol. Chem. 281 (2006) 40429-40439
101. Ding G., Fu M., Qin Q., Lewis W., Kim H.W., Fukai T., Bacanamwo M., Chen Y.E., Schneider M.D., Mangelsdorf D.J., Evans R.M., and Yang Q. Cardiac peroxisome proliferator-activated receptor gamma is essential in protecting cardiomyocytes from oxidative damage. Cardiovasc. Res. 76 (2007) 269-279
102. Jeney V., Itoh S., Wendt M., Gradek Q., Ushio-Fukai M., Harrison D.G., and Fukai T. Role of antioxidant-1 in extracellular superoxide dismutase function and expression. Circ. Res. 96 (2005) 723-729
103. Qin Z., Itoh S., Jeney V., Ushio-Fukai M., and Fukai T. Essential role for the Menkes ATPase in activation of extracellular superoxide dismutase: implication for vascular oxidative stress. FASEB J. 20 (2006) 334-336
104. Qin Z., Gongora M.C., Ozumi K., Itoh S., Akram K., Ushio-Fukai M., Harrison D.G., and Fukai T. Role of Menkes ATPase in angiotensin II-induced hypertension: a key modulator for extracellular superoxide dismutase function. Hypertension 52 (2008) 945-951
105. Zelko I.N., and Folz R.J. Myeloid zinc finger (MZF)-like, Kruppel-like and Ets families of transcription factors determine the cell-specific expression of mouse extracellular superoxide dismutase. Biochem. J. 369 (2003) 375-386
106. Huang Y., He T., and Domann F.E. Decreased expression of manganese superoxide dismutase in transformed cells is associated with increased cytosine methylation of the SOD2 gene. DNA Cell Biol. 18 (1999) 643-652
107. Hitchler M.J., Wikainapakul K., Yu L., Powers K., Attatippaholkun W., and Domann F.E. Epigenetic regulation of manganese superoxide dismutase expression in human breast cancer cells. Epigenetics 1 (2006) 163-171
108. Hitchler M.J., Oberley L.W., and Domann F.E. Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells. Free Radic. Biol. Med. 45 (2008) 1573-1580
109. Hurt E.M., Thomas S.B., Peng B., and Farrar W.L. Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines. Br. J. Cancer 97 (2007) 1116-1123
110. Hodge D.R., Peng B., Pompeia C., Thomas S., Cho E., Clausen P.A., Marquez V.E., and Farrar W.L. Epigenetic silencing of manganese superoxide dismutase (SOD-2) in KAS 6/1 human multiple myeloma cells increases cell proliferation. Cancer Biol. Ther. 4 (2005) 585-592
111. Maehara K., Uekawa N., and Isobe K. Effects of histone acetylation on transcriptional regulation of manganese superoxide dismutase gene. Biochem. Biophys. Res. Commun. 295 (2002) 187-192
112. Oates N., and Pamphlett R. An epigenetic analysis of SOD1 and VEGF in ALS. Amyotroph. Lateral Scler. 8 (2007) 83-86
113. Hirsch S., Ronco A.M., Guerrero-Bosagna C., de la Maza M.P., Leiva L., Barrera G., Llanos M., Alliende M.A., Silva F., and Bunout D. Methylation status in healthy subjects with normal and high serum folate concentration. Nutrition 24 (2008) 1103-1109
114. Laukkanen M.O., Mannermaa S., Hiltunen M.O., Aittomaki S., Airenne K., Janne J., and Yla-Herttuala S. Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2171-2178
115. Davis C.A., Monnier J.M., and Nick H.S. A coding region determinant of instability regulates levels of manganese superoxide dismutase mRNA. J. Biol. Chem. 276 (2001) 37317-37326
116. Stuart J.J., Egry L.A., Wong G.H., and Kaspar R.L. The 3′ UTR of human MnSOD mRNA hybridizes to a small cytoplasmic RNA and inhibits gene expression. Biochem. Biophys. Res. Commun. 274 (2000) 641-648
117. Smalheiser N.R., and Torvik V.I. Alu elements within human mRNAs are probable microRNA targets. Trends Genet. 22 (2006) 532-536
118. Rabani M., Kertesz M., and Segal E. Computational prediction of RNA structural motifs involved in posttranscriptional regulatory processes. Proc. Natl. Acad. Sci. USA 105 (2008) 14885-14890
119. Fazzone H., Wangner A., and Clerch L.B. Rat lung contains a developmentally regulated manganese superoxide dismutase mRNA-binding protein. J. Clin. Invest. 92 (1993) 1278-1281
120. Chung D.J., and Clerch L.B. RNA in polysomes is an inhibitor of manganese superoxide dismutase RNA-binding protein activity. Am. J. Physiol. 272 (1997) L714-L719
121. Clerch L.B. Post-transcriptional regulation of lung antioxidant enzyme gene expression. Ann. N.Y. Acad. Sci. 899 (2000) 103-111
122. Chung D.J., Wright A.E., and Clerch L.B. The 3′ untranslated region of manganese superoxide dismutase RNA contains a translational enhancer element. Biochemistry 37 (1998) 16298-16306
123. Knirsch L., and Clerch L.B. A region in the 3′ UTR of MnSOD RNA enhances translation of a heterologous RNA. Biochem. Biophys. Res. Commun. 272 (2000) 164-168
124. Knirsch L., and Clerch L.B. Tyrosine phosphorylation regulates manganese superoxide dismutase (MnSOD) RNA-binding protein activity and MnSOD protein expression. Biochemistry 40 (2001) 7890-7895
125. Kilk A., Laan M., and Torp A. Human CuZn superoxide dismutase enzymatic activity in cells is regulated by the length of the mRNA. FEBS Lett. 362 (1995) 323-327
126. Shaw P.J., Tomkins J., Slade J.Y., Usher P., Curtis A., Bushby K., and Ince P.G. CNS tissue Cu/Zn superoxide dismutase (SOD1) mutations in motor neurone disease (MND). NeuroReport 8 (1997) 3923-3927
127. Mirossay A., Jun S., and Dory L. Cloning and characterization of two alleles of the murine extracellular superoxide dismutase gene. Biochem. Biophys. Res. Commun. 352 (2007) 739-743
128. Okado-Matsumoto A., and Fridovich I. Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu,Zn-SOD in mitochondria. J. Biol. Chem. 276 (2001) 38388-38393
129. Orrell R., de Belleroche J., Marklund S., Bowe F., and Hallewell R. A novel SOD mutant and ALS. Nature 374 (1995) 504-505
130. Rosen D.R. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364 (1993) 362
131. Turner B.J., and Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog. Neurobiol. 85 (2008) 94-134
132. Wroe R., Wai-Ling Butler A., Andersen P.M., Powell J.F., and Al-Chalabi A. ALSOD: the Amyotrophic Lateral Sclerosis Online Database. Amyotroph. Lateral Scler. 9 (2008) 249-250
133. Niemann S., Broom W.J., and Brown Jr. R.H. Analysis of a genetic defect in the TATA box of the SOD1 gene in a patient with familial amyotrophic lateral sclerosis. Muscle Nerve 36 (2007) 704-707
134. Bruijn L.I., Miller T.M., and Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27 (2004) 723-749
135. Furukawa Y., Kaneko K., Yamanaka K., O'Halloran T.V., and Nukina N. Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis. J. Biol. Chem. 283 (2008) 24167-24176
136. Valentine J.S., Doucette P.A., and Zittin Potter S. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu. Rev. Biochem. 74 (2005) 563-593
137. Borgstahl G.E., Parge H.E., Hickey M.J., Beyer Jr. W.F., Hallewell R.A., and Tainer J.A. The structure of human mitochondrial manganese superoxide dismutase reveals a novel tetrameric interface of two 4-helix bundles. Cell 71 (1992) 107-118
138. Beckman J.S., Esetvez A.G., Barbeito L., and Crow J.P. CCS knockout mice establish an alternative source of copper for SOD in ALS. Free Radic. Biol. Med. 33 (2002) 1433-1435
139. Furukawa Y., and O'Halloran T.V. Posttranslational modifications in Cu,Zn-superoxide dismutase and mutations associated with amyotrophic lateral sclerosis. Antioxid. Redox Signal. 8 (2006) 847-867
140. Carroll M.C., Outten C.E., Proescher J.B., Rosenfeld L., Watson W.H., Whitson L.J., Hart P.J., Jensen L.T., and Cizewski Culotta V. The effects of glutaredoxin and copper activation pathways on the disulfide and stability of Cu,Zn superoxide dismutase. J. Biol. Chem. 281 (2006) 28648-28656
141. Crow J.P., Sampson J.B., Zhuang Y., Thompson J.A., and Beckman J.S. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J. Neurochem. 69 (1997) 1936-1944
142. Estevez A.G., Crow J.P., Sampson J.B., Reiter C., Zhuang Y., Richardson G.J., Tarpey M.M., Barbeito L., and Beckman J.S. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286 (1999) 2498-2500
143. Roberts B.R., Tainer J.A., Getzoff E.D., Malencik D.A., Anderson S.R., Bomben C., Meyers K.R., Karplus P.A., and Beckman J.S. Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS. J. Mol. Biol. 373 (2007) 877-890
144. Groeneveld G.J., de Leeuw van Weenen J., van Muiswinkel F.L., Veldman H., Veldink J.H., Wokke J.H., Bar P.R., and van den Berg L.H. Zinc amplifies mSOD1-mediated toxicity in a transgenic mouse model of amyotrophic lateral sclerosis. Neurosci. Lett. 352 (2003) 175-178
145. Ermilova I.P., Ermilov V.B., Levy M., Ho E., Pereira C., and Beckman J.S. Protection by dietary zinc in ALS mutant G93A SOD transgenic mice. Neurosci. Lett. 379 (2005) 42-46
146. McCord J.M., and Fridovich I. Superoxide dismutase: the first twenty years (1968-1988). Free Radic. Biol. Med. 5 (1988) 363-369
147. Oberley L.W., and Buettner G.R. Role of superoxide dismutase in cancer: a review. Cancer Res. 39 (1979) 1141-1149
148. Carlioz A., and Touati D. Isolation of superoxide dismutase mutants in Escherichia coli: is superoxide dismutase necessary for aerobic life?. EMBO J. 5 (1986) 623-630
149. Li Y., Huang T.T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., Noble L.J., Yoshimura M.P., Berger C., Chan P.H., Wallace D.C., and Epstein C.J. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 11 (1995) 376-381
150. Lebovitz R.M., Zhang H., Vogel H., Cartwright Jr. J., Dionne L., Lu N., Huang S., and Matzuk M.M. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl. Acad. Sci. USA 93 (1996) 9782-9787
151. Kinnula V.L., and Crapo J.D. Superoxide dismutases in malignant cells and human tumors. Free Radic. Biol. Med. 36 (2004) 718-744
152. Oberley L.W. Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomed. Pharmacother. 59 (2005) 143-148
153. Devi G.S., Prasad M.H., Saraswathi I., Raghu D., Rao D.N., and Reddy P.P. Free radicals antioxidant enzymes and lipid peroxidation in different types of leukemias. Clin. Chim. Acta 293 (2000) 53-62
154. Hu Y., Rosen D.G., Zhou Y., Feng L., Yang G., Liu J., and Huang P. Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress. J. Biol. Chem. 280 (2005) 39485-39492
155. Xu Y., Krishnan A., Wan X.S., Majima H., Yeh C.C., Ludewig G., Kasarskis E.J., and St Clair D.K. Mutations in the promoter reveal a cause for the reduced expression of the human manganese superoxide dismutase gene in cancer cells. Oncogene 18 (1999) 93-102
156. Rosenblum J.S., Gilula N.B., and Lerner R.A. On signal sequence polymorphisms and diseases of distribution. Proc. Natl. Acad. Sci. USA 93 (1996) 4471-4473
157. Borgstahl G.E., Parge H.E., Hickey M.J., Johnson M.J., Boissinot M., Hallewell R.A., Lepock J.R., Cabelli D.E., and Tainer J.A. Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the tetrameric interface. Biochemistry 35 (1996) 4287-4297
158. Hernandez-Saavedra D., and McCord J.M. Paradoxical effects of thiol reagents on Jurkat cells and a new thiol-sensitive mutant form of human mitochondrial superoxide dismutase. Cancer Res. 63 (2003) 159-163
159. Nakanishi S., Yamane K., Ohishi W., Nakashima R., Yoneda M., Nojima H., Watanabe H., and Kohno N. Manganese superoxide dismutase Ala16Val polymorphism is associated with the development of type 2 diabetes in Japanese-Americans. Diabetes Res. Clin. Pract. 81 (2008) 381-385
160. Hirooka Y. Role of reactive oxygen species in brainstem in neural mechanisms of hypertension. Auton. Neurosci. 142 (2008) 20-24
161. Arsova-Sarafinovska Z., Matevska N., Petrovski D., Banev S., Dzikova S., Georgiev V., Sikole A., Sayal A., Aydin A., Suturkova L., and Dimovski A.J. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer. Cell Biochem. Funct. 26 (2008) 771-777
162. Mikhak B., Hunter D.J., Spiegelman D., Platz E.A., Wu K., Erdman Jr. J.W., and Giovannucci E. Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels, and prostate cancer risk. Carcinogenesis 29 (2008) 2335-2340
163. St Clair D., and Kasarskis E. Genetic polymorphism of the human manganese superoxide dismutase: what difference does it make?. Pharmacogenetics 13 (2003) 129-130
164. Sutton A., Khoury H., Prip-Buus C., Cepanec C., Pessayre D., and Degoul F. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 13 (2003) 145-157
165. Bag A., and Bag N. Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review. Cancer Epidemiol. Biomark. Prev. 17 (2008) 3298-3305
166. Wheatley-Price P., Asomaning K., Reid A., Zhai R., Su L., Zhou W., Zhu A., Ryan D.P., Christiani D.C., and Liu G. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma. Cancer 112 (2008) 1037-1042
167. Liu G., Zhou W., Park S., Wang L.I., Miller D.P., Wain J.C., Lynch T.J., Su L., and Christiani D.C. The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms. Cancer 101 (2004) 2802-2808
168. Holla L.I., Kankova K., and Vasku A. Functional polymorphism in the manganese superoxide dismutase (MnSOD) gene in patients with asthma. Clin. Biochem. 39 (2006) 299-302
169. Singh M., Khan A.J., Shah P.P., Shukla R., Khanna V.K., and Parmar D. Polymorphism in environment responsive genes and association with Parkinson disease. Mol. Cell. Biochem. 312 (2008) 131-138
170. Li H., Kantoff P.W., Giovannucci E., Leitzmann M.F., Gaziano J.M., Stampfer M.J., and Ma J. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res. 65 (2005) 2498-2504
171. Ho J.C., Mak J.C., Ho S.P., Ip M.S., Tsang K.W., Lam W.K., and Chan-Yeung M. Manganese superoxide dismutase and catalase genetic polymorphisms, activity levels, and lung cancer risk in Chinese in Hong Kong. J. Thorac. Oncol. 1 (2006) 648-653
172. Woodson K., Tangrea J.A., Lehman T.A., Modali R., Taylor K.M., Snyder K., Taylor P.R., Virtamo J., and Albanes D. Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland). Cancer Causes Control 14 (2003) 513-518
173. Olson S.H., Carlson M.D., Ostrer H., Harlap S., Stone A., Winters M., and Ambrosone C.B. Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer. Gynecol. Oncol. 93 (2004) 615-620
174. Zhang H.J., Yan T., Oberley T.D., and Oberley L.W. Comparison of effects of two polymorphic variants of manganese superoxide dismutase on human breast MCF-7 cancer cell phenotype. Cancer Res. 59 (1999) 6276-6283
175. Marklund S.L. Human copper-containing superoxide dismutase of high molecular weight. Proc. Natl. Acad. Sci. USA 79 (1982) 7634-7638
176. Marklund S.L., Holme E., and Hellner L. Superoxide dismutase in extracellular fluids. Clin. Chim. Acta 126 (1982) 41-51
177. Marklund S.L. Extracellular superoxide dismutase. Methods Enzymol. 349 (2002) 74-80
178. Karlsson K., Lindahl U., and Marklund S.L. Binding of human extracellular superoxide dismutase C to sulphated glycosaminoglycans. Biochem. J. 256 (1988) 29-33
179. Tibell L.A., Sethson I., and Buevich A.V. Characterization of the heparin-binding domain of human extracellular superoxide dismutase. Biochim. Biophys. Acta 1340 (1997) 21-32
180. Gao F., Koenitzer J.R., Tobolewski J.M., Jiang D., Liang J., Noble P.W., and Oury T.D. Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan. J. Biol. Chem. 283 (2008) 6058-6066
181. Sandstrom J., Nilsson P., Karlsson K., and Marklund S.L. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J. Biol. Chem. 269 (1994) 19163-19166
182. Adachi T., Yamada H., Yamada Y., Morihara N., Yamazaki N., Murakami T., Futenma A., Kato K., and Hirano K. Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface. Biochem. J. 313 Pt 1 (1996) 235-239
183. Qin Z., Reszka K.J., Fukai T., and Weintraub N.L. Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD. Transl. Res. 151 (2008) 68-78
184. Campo S., Sardo A.M., Campo G.M., D'Ascola A., Avenoso A., Castaldo M., Saitta C., Lania A., Saitta A., and Calatroni A. Extracellular superoxide dismutase (EC-SOD) gene mutations screening in a sample of Mediterranean population. Mutat. Res. 578 (2005) 143-148
185. Tamai M., Furuta H., Kawashima H., Doi A., Hamanishi T., Shimomura H., Sakagashira S., Nishi M., Sasaki H., Sanke T., and Nanjo K. Extracellular superoxide dismutase gene polymorphism is associated with insulin resistance and the susceptibility to type 2 diabetes. Diabetes Res. Clin. Pract. 71 (2006) 140-145
186. Petersen S.V., Oury T.D., Valnickova Z., Thogersen I.B., Hojrup P., Crapo J.D., and Enghild J.J. The dual nature of human extracellular superoxide dismutase: one sequence and two structures. Proc. Natl. Acad. Sci. USA 100 (2003) 13875-13880
187. Petersen S.V., Kristensen T., Petersen J.S., Ramsgaard L., Oury T.D., Crapo J.D., Nielsen N.C., and Enghild J.J. The folding of human active and inactive extracellular superoxide dismutases is an intracellular event. J. Biol. Chem. 283 (2008) 15031-15036
188. Olsen D.A., Petersen S.V., Oury T.D., Valnickova Z., Thogersen I.B., Kristensen T., Bowler R.P., Crapo J.D., and Enghild J.J. The intracellular proteolytic processing of extracellular superoxide dismutase (EC-SOD) is a two-step event. J. Biol. Chem. 279 (2004) 22152-22157
189. Gongora M.C., Qin Z., Laude K., Kim H.W., McCann L., Folz J.R., Dikalov S., Fukai T., and Harrison D.G. Role of extracellular superoxide dismutase in hypertension. Hypertension 48 (2006) 473-481
190. Nguyen A.D., Itoh S., Jeney V., Yanagisawa H., Fujimoto M., Ushio-Fukai M., and Fukai T. Fibulin-5 is a novel binding protein for extracellular superoxide dismutase. Circ. Res. 95 (2004) 1067-1074